课题基金 / 基金详情

PROTEASE INHIBITORS USED IN THE TREATMENT OF HIV+ INDUCE BETA-CELL

PROTEASE INHIBITORS USED IN THE TREATMENT OF HIV+ INDUCE BETA-CELL
用于治疗艾滋病毒的蛋白酶抑制剂诱导β细胞
批准号：
8361416
负责人：
Sheng Zhang
金额：
$2.98万
依托单位：
WASHINGTON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
项目状态：
已结题
起止时间：
2011-01-01 至 2011-12-31
来源：
https://reporter.nih.gov/project-details/8361416
关键词：
Beta CellFundingGrantHIVHIV Protease InhibitorsIncidenceLifeMass Spectrum AnalysisMetabolicNational Center for Research ResourcesPrincipal InvestigatorProtease InhibitorResearchResearch InfrastructureResourcesSourceUnited States National Institutes of Healthbiomedical resourcecostmortality

项目摘要

项目成果

Sheng Zhang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Inclusion of HIV protease inhibitors (PIs) in the treatment of people living with HIV+ has markedly decreased mortality but also increased the incidence of metabolic abnormalities, causes of which are not well understood.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
The Roles of Huntingtin Associated Protein 40 in Huntingtin Functions and Huntington's Disease Pathogenesis
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
海外基金